Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Caribou Biosciences (CRBU) Accumulated Depreciation & Amortization (2020 - 2025)

Historic Accumulated Depreciation & Amortization for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to $3.0 million.

  • Caribou Biosciences' Accumulated Depreciation & Amortization rose 802.04% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 802.04%. This contributed to the annual value of $3.9 million for FY2024, which is 1140.43% up from last year.
  • According to the latest figures from Q3 2025, Caribou Biosciences' Accumulated Depreciation & Amortization is $3.0 million, which was up 802.04% from $2.3 million recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Accumulated Depreciation & Amortization registered a high of $3.9 million during Q4 2024, and its lowest value of $308000.0 during Q1 2022.
  • For the 5-year period, Caribou Biosciences' Accumulated Depreciation & Amortization averaged around $1.8 million, with its median value being $1.4 million (2023).
  • Per our database at Business Quant, Caribou Biosciences' Accumulated Depreciation & Amortization plummeted by 8120.77% in 2022 and then skyrocketed by 14955.2% in 2023.
  • Caribou Biosciences' Accumulated Depreciation & Amortization (Quarter) stood at $984000.0 in 2021, then skyrocketed by 64.84% to $1.6 million in 2022, then skyrocketed by 117.32% to $3.5 million in 2023, then grew by 11.4% to $3.9 million in 2024, then fell by 24.55% to $3.0 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $3.0 million for Q3 2025, versus $2.3 million for Q2 2025 and $1.2 million for Q1 2025.